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ABSTRACT
A major function of the brain choroid plexus (CP) is to regulate the exchange of solutes
between the blood plasma and the cerebrospinal fluid (CSF) using selective transporters. CSF
inorganic phosphate (Pi) concentration is maintained at about one-half that of plasma and is
potentially important because of its regulatory, structural, and biochemical functions. Phosphate
is critical for ATP and DNA formation, the linked regulation between phosphate and calcium,
and as an intracellular buffer. The human body has two major Pi transporter gene families known
as SLC34 (NaPi-II) and SLC20 (PiT), which have wide tissue distribution. Although both
families are secondary-active and sodium-dependent, they are distinguished by their transport
mechanisms and functional properties. NaPi-II-type and PiT-type transporters are characterized
by their substrate stoichiometry and inhibition profile. Unlike NaPi-II-type transporters, PiT-type
transporters are not inhibited by phosphonoformic acid (PFA) and can partially substitute Li+ for
Na+. Bataille et al. (unpublished) used these differences to characterize the effects of arsenate,
PFA, and Li+ on CP phosphate transport. The results indicate that a PiT-type transporter is
responsible for Pi transport in the CP. To further support this hypothesis, RT-PCR and western
blotting were performed to definitively determine if NaPi-II-type transporters are present or
absent from the CP. The results confirm the presence of PiT-like transporters but also indicate
that NaPi-IIb is potentially present in the CP. Thus, the secondary-active, CP transport of
phosphate out of the CSF may involve more than one family of solute carrier transporters.
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1. INTRODUCTION
1.1 The Choroid Plexus and CSF Formation
Also known as the “kidney of the brain,” the choroid plexus (CP) tissues are
interventricular organ that secrete two-thirds of total cerebrospinal fluid and mediate the
transport of solutes between the blood plasma to the cerebrospinal fluid (CSF) (10, 32). The CP
is divided into four parts with tissues in each lateral ventricle, third ventricle, and fourth
ventricle, as seen in Figure 1(28). CP tissue is comprised of a continuous monolayer of cuboidal
and columnar epithelial cells that is situated on connective tissue (Figure 2). The lateral
ventricles of the mammalian brain have sheet-like choroid plexus structures, whereas the choroid
plexuses in the third and four ventricles are branched villi that protrude into the ventricle (7).
Each villus has a central vascular axis that is covered by ciliated cuboidal epithelium with
numerous mitochondria. The epithelium also contains dendritic cells, which suggests that the CP
may play in active role in immunological brain protection (28).
The CP is paired with the fenestrated endothelium of the cerebral capillary beds to form
the blood-CSF barrier (Figure 3) (10). The epithelium layer folds into numerous small villi to
increase surface area and is designated as the major barrier of substrate movement between the
blood and CSF (7). One of the CP’s major functions is to transport essential CSF electrolytes,
such as Na+, Cl-, HCO3-, K+, and the topic of this report, inorganic phosphate (Pi), across its
epithelium (32). In addition to epithelial transport, the CP is responsible for the majority (twothirds) of total CSF production. Extrachoroidal sites make up the latter third of total CSF
production with less than 10% of total CSF formation coming from brain interstitial fluid and the
rest originating from water produced in the brain cells by glucose oxidation and ultrafiltration
across the cerebral microvessels (23). The rate of CSF production is relatively high compared to
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total human CSF volume (150-170 mL), suggesting that CSF is constantly renewed and old fluid
is removed by bulk flow. Over a 24 hour period, it has been estimated that ~600 mL of CSF is
produced, a large enough volume to replace existing CSF three to four times (23). CSF
production begins with passive filtration of fluid across choroidal capillary endothelium followed
by active secretion across the CP (10).
The role of the CP in CSF production is important because the CSF physically and
chemically protects the brain. The buoyancy of CSF reduces the weight of the brain nearly 30fold, from 1,500 grams to approximately 50 grams. This translates into a decreased pressure on
blood vessels and nerves attached to the CNS. Moreover, the buoyant nature of CSF prevents the
cerebrum from crushing the brainstem and serves as a mechanical buffer to protect the CNS from
damage caused by physical impact to the skull (7, 23, 29). To maintain a stable environment
within the intraventricular milieu, CSF is constantly secreted which then displaces older fluid.
This is important because the brain lacks lymphatic capillaries, and CSF flow assists in the
removal of waste products, debris, bacteria, and viruses (10, 29). CSF flow starts within the
ventricle cavities, into the subarachnoid space, and finally drains into the systemic circulation via
the dural sinuses (Figure 4) (7, 29). The fluid flows unidirectionally due to the presence of valvelike mechanisms to prevent the regurgitation of blood into the subarachnoid space (6).
Because of the brain’s special metabolic requirements, the composition of CSF is vital to
brain health. Neurons require a constant glucose and oxygen supply for ATP synthesis to fuel
active transport of ions and neurotransmitters. Thus, the brain receives 15% of the blood pumped
by the heart (29). To illustrate the importance of the choroid plexus, the blood flow to the CP is
10 times higher than the blood flow to the brain parenchyma and five times higher than the blood
flow to the kidney, on a per gram basis. The adult human CP secretes the equivalent of 10% of
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the received blood flow or approximately 0.5 liters/day. Despite fluctuations in blood flow and
pressure, the CP is remarkable at balancing CSF production and reabsorption to maintain an
intracranial pressure between 5-15 mm Hg above that of the arterial blood. Moreover, the CP is
extraordinary at keeping CSF composition constant over time despite changes in the blood
compartment. For instance, CSF [K+] increases by less than 2 mM when plasma [K+] changes
from 1.6 to 11 mM (7). The ability to finely control CSF formation has been a challenge but is
clinically important due to its relation to brain fluid disorders such as congenital hydrocephaly.
Congenital hydrocephalus is one of the most common birth defects, affecting up to 1 in 500
births and is severe because it disrupts brain development, which ultimately decreases
neurogenesis (13). Most attempts to regulate CSF formation are focused on altering ion
movement via transporters in the membranes of CP epithelium (10).

1.2 Phosphate in Physiological Systems
Pi is an essential dietary nutrient that is absorbed from food as an electrically charged salt
anion. In fact, phosphorus is the sixth most abundant element in the body (9). Approximately
85% of Pi in the body is found in the bones, 14% is in the cells of soft tissues, and the remaining
1% is in extracellular fluids (16). Extracellular [Pi] must be stable at ~1.1 mM for proper cellular
function (18). The CSF has a Pi concentration held between 0.5 mM and 1.0 mM, whereas the
plasma has a [Pi] range between 1.5 to 1.8 mM (2). The reason for the lower CSF [Pi] relative to
plasma [Pi] is unexplained.
Every cell requires Pi for structural, metabolic, and regulatory purposes. Examples of
cellular structures that incorporate phosphate are the DNA backbone, phospholipids in the cell
membranes, and phosphoproteins that are necessary for mitochondrial function. Moreover,
important intracellular compounds such as cyclic adenine and the enzymatic co-factor
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nictoniamide diphosphate are dependent on intracellular phosphate pools for their formation
(24).
Another physiological function of phosphate is the regulation of intracellular processes,
such as protein, fat, and carbohydrate metabolism. Phosphorylation is a major regulatory process
that may directly modulate numerous enzymatic reactions, including glycolysis and
ammoniagenesis. Pi seems to have its most obvious role as the source of the high-energy bonds
in ATP. The energy stored in ATP provides the energy for vital physiological processes such as
muscle contractility and electrolyte transport (29). Because of ATP’s various functions within
the cell, Pi is an indicator of cellular metabolic capability.
Pi is a triprotic acid and it loses its three hydrogen’s sequentially (29):
1. H3PO4 (aq)՞ H+(aq) + H2PO4-(aq)
2. H2PO4- (aq)՞ H+(aq) + HPO42-(aq)
3. HPO42- (aq)՞ H+(aq) + PO43-(aq)
Physiological Pi is present in two forms H2PO4- and HPO42- and is a nearly ideal
physiological buffer, as represented by equation 2 and evident by its 7.21 pKa (6). Eighty percent
of plasma Pi is in the divalent form at physiological pH, which is slightly alkaline at 7.38-7.40 .
H+ concentrations must be tightly regulated because dramatic changes in pH will disrupt the
protein’s tertiary structure, leading to dysfunction. In the CNS, pH fluctuations may cause dire
consequences. Acidosis can result in less excitable neurons and ultimately CNS depression.
Patients exhibiting CNS depression are confused and disoriented and can potentially slip into a
coma. If CNS depression continues, the respiratory centers fail, resulting in death. On the other
hand, if the pH is too high, alkalosis causes neurons to become hyperexcitable, initiating action
potentials at the slightest signal. At first, the condition clinically presents itself as sensory
changes, such as numbness or tingling, and subsequently as muscle twitches (29). To prevent
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these disorders, buffers are used as a first line of defense. The most common intracellular buffers
are proteins and notably, Pi. Unlike plasma, CSF has an almost complete lack of protein (less
than 0.5 g/L), yet the CSF pH is very stable. Changes in the concentration of plasma HCO3- have
little effect on CSF [HCO3-]. However, an elevation in blood PCO2 results in an increase in CSF
PCO2 but not as high as predicted. Thus, there must be some sort of mechanism that regulates pH,
and Pi is a potential candidate to explain this phenomenon. Interestingly, a 0.05 unit drop in CSF
pH causes a 10-fold increase in ventilation rate (7).
Varying Pi concentrations influence Ca2+ concentrations. Their regulation is linked which
is further supported by the contribution of several organs and hormones that control both their
concentrations. Intestinal absorption, bone (de)mineralization, and renal reabsorption/excretion
are all affected by the same hormones that increase or decrease plasma [Ca2+] or [Pi]. For
example, parathyroid hormone (PTH) increases plasma [Ca2+] by enhancing renal reabsorption
and decreasing plasma [Pi] by increasing renal excretion. PTH also causes the mobilization of
calcium from bones, resulting in a release of Pi (24). This is because 99% of Ca2+ and Pi are
found in the bones in the form of hydroxyapatite, Ca10(PO4)6(OH)2 (19, 29). Although it is
unknown whether hormones influence CP Pi transport, it is still pertinent to consider the effects
of Pi on Ca2+ concentrations.
The relationship between Pi and Ca2+ concentrations is relevant because of the several
physiological functions of calcium. Cells use calcium for intracellular signaling to initiate a
variety of essential processes. For example, calcium initiates the exocytosis of synaptic and
secretory vesicles and the contraction of muscle fibers. If plasma Ca2+ levels are not tightly
controlled, neuron excitability can be induced. Hypocalcemia increases neuronal permeability to
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Na+, causing neuronal depolarization and CNS hyperexcitability. On the other hand,
hypercalcemia, causes neuromuscular depression (29).

1.3 Phosphate Transporters: SLC20 versus SLC34
Cells acquire Pi from extracellular fluid by secondary-active transport. Pi transporters
drive Pi influx by utilizing the inwardly directed electrochemical Na+ gradient formed by Na+K+-ATPase. The two major Pi transporters are called NaPi-II (SLC34) and PiT (SLC20) and are
similar in that they are both secondary active and Na+-coupled (33). However, the two solute
protein carriers are distinguished by their mechanistic properties and physiological roles.

SLC34 Transporter Family
The type II Na/Pi protein has three isoforms known as NaPi-IIa (SLC34A1), NaPi-IIb
(SLC34A2), and NaPi-IIc (SLC34A3). Pi transporters from the SLC34 gene family are most
highly expressed in the small intestine and in the renal proximal tubules, the two most important
sites for controlling systemic Pi concentrations (18). The importance of the SLC34 transporter
family is conveyed by the hyperphosphaturia, hypophosphatemia, and increased renal stone
incidence documented in NaPi-IIa (Npt2a-/-) knockout mice and the presence of osteoporosis and
nephrolithiasis in heterozygous mutated NaPi-IIa mice (Npt2a+/-) (20, 33).
NaPi-II isoforms are differentially expressed throughout the body. Specifically, NaPi-IIa
transporters have been found in bone and kidney, NaPi-IIb transporters are expressed in
enterocytes and lung tissue, and NaPi-IIc transporters are exclusively seen in the kidney (18). All
NaPi-II isoforms prefer the divalent Pi and are strictly dependent on Na+. An important
difference between SLC20 and SLC34 is that the latter is inhibited by phosphonoformic acid
(PFA), which makes NaPi-II identifiable during transport studies (33).
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NaPi-IIa-type transporters are an 80-90 kDa protein that is principally localized in the
microvilli that make up the brush border membrane of the renal proximal tubule. NaPi-IIa
transport cycles are electrogenic and characterized by an inward transfer of one net positive
charge per cycle. Three Na+ ions and one HPO42- bind to the NaPi-II protein in a Na+/Pi/Na+
ordered manner, with substrate affinities of KmPi ~0.1 mM and KmNa ~70 mM. Transport rates are
higher at more alkaline external pH values (18). Targeted type IIa knockout mice have
demonstrated that NaPi co-transport in brush-border membrane vesicles is reduced by 70%,
indicating that most proximal tubule Pi is by NaPi-IIa transporters (16).
NaPi-IIb mRNA expression has been identified in a variety of tissues that include the
lung, small intestines, testis, mammary glands, and the liver. Immunofluorescence has indicated
that NaPi-IIb-type transporters are localized to the brush borders of enterocytes and the apical
membrane of alveolar type II cells. The fully glycosylated 108 kDa protein transports in an
electrogenic, 3Na: 1Pi stoichiometric fashion and has a binding affinity of KmPi <50 µM and
KmNa+ ~40 mM. There is moderate pH dependence, with a slightly higher co-transport at more
acidic pH values (18). Although western blots have detected glycosylated proteins at 108 kDa,
NaPi-IIb transporters have been observed to only be partially glycosylated in weaning animals
(18). NaPi-IIb (Npt2b+/- and Npt2b-/-) knockout mice have been phenotypically analyzed and all
Npt2b-/- mice died in utero, suggesting that NaPi-IIb-type transporters are essential for early
embryonic development. In contrast, weaning hetero Npt2b+/- mice display hypophosphatemia
and hypophosphaturia. Moreover, Ohi et al. showed that Npt2b+/- mice with adenine-induced
renal failure had decreased plasma Pi levels compared with the level in Npt2b+/+ mice. These
knockout studies demonstrate that NaPi-IIb is important as a therapeutic target for the prevention
of hyperphosphatemia and is a regulator of systemic Pi homeostasis (19).

Le 12
The last SLC34 isoform, NaPi-IIc, is found exclusively on the apical membranes of the
proximal tubules of the deep nephrons. In contrast to its counterparts, the 75 kDa protein is
electroneutral with a transport Na:Pi stoichiometry of 2:1. Substrate affinity is KmPi 70 µM and
KmNa 40 mM. NaPi-IIc is highly pH dependent and exhibits a higher transport at more alkaline
pH (18, 27). Type IIc NaPi-knockout mice models have shown that it is responsible for residual
Pi transport and accounts for 30% of renal Pi reabsorption (16). NaPi-IIc transporters are
described as growth related. While the level of type IIa NaPi transporters increase with age,
NaPi-IIc protein expression decreases with age and has its greatest expression in weaning
animals. In the adult kidney, NapI-IIc transporters are localized to the midcortical region of the
adult kidney but are found in the midcortical and superficical region in the kidney of weaning
animals. In Npt2a-/- mouse kidneys, NaPi-IIc protein expression increased with age and persisted
until adulthood [unpublished observation] (15). The high levels of the type-IIc isoform may
compensate for reduced [Pi] transport when NaPi-IIa expression is low to support growth in
Npt2a-/- mice.

SLC20 Transporter Family
Also described as retroviral receptors, the SLC20 solute carrier family preferentially
transports Na+ and the monovalent H2PO4-. Two isoforms, PiT1(SLC20A1) and PiT2
(SLC20A2) make up the SLC20 family and share ~60% sequence homology (4, 33). The PiT
proteins have wide tissue distribution but each isoform is differentially expressed. Unfortunately,
there is only limited data on the distribution and subcellular localization of PiT1 and PiT2
proteins. Some precise localization studies have shown that PiT expression in the distal
convoluted tubule in the kidney and PiT2 mRNA has been found in epithelial cells along the
crypt/villus axis in mouse small intestinal cells. Moreover, PiT1 mRNA has been detected in
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osteoclasts and macrophages and transfected PiT1 proteins have localized to the basolateral
membrane (33). Although the physiological role of SLC20 proteins has not been definitive, it has
been suggested that PiT paralogs are cellular “housekeeping” proteins that maintain cellular Pi
homeostasis. This is because SLC20 proteins are likely to have basolateral localization within
epithelial cells and there is an upregulation of PiT protein expression when extracellular Pi levels
are low (3, 4).
The PiT1 and PiT2 co-transporters specifically mediate the movement of Na+ and Pi
across the cell membrane and have many distinguishing transport mechanisms. Both PiT proteins
have a Na+:Pi transport stoichiometry of 2:1, and because the preferred substrate is H2PO4-, their
transport is electrogenic. Unlike NaPi-II-type transporters, PiT proteins can substitute Na+ with
Li+ to support Pi transport. Additionally, two studies have indicated that H+ can support Pi
transport to a small extent in the absence of Na+. The optimal pH range for PiT1 and PiT2 Pi
transport is between 6.2 and 8.0, and lowering the pH from 7.5 to 6.0 significantly increased Pi
transport across the cell membrane. This is different from NaPi-II-mediated transport, which is
strongly reduced at acidic pH because of the inhibitory effects of H+ and the decreased
availability of HPO42-. Thus, PiT proteins are able to transport Pi at pH’s as acidic as 5.0 (3, 33).
Another distinguishing characteristic of PiT-mediated transport is the involvement of
divalent ions. In the absence of Ca2+ and Mg2+, PiT1 and PiT2 Pi transport is impaired, yet
sufficient. PiT1 and PiT2 transport was ~54% and ~58% of the transport in the absence of both
divalent cations, respectively. Neither SLC20 protein is strictly dependent on Ca2+ and/or Mg2+,
but studies have indicated that Mg2+ is dispensable as long as Ca2+ is present. Ca2+ involvement
increased Pi transport the greatest, indicating that Ca2+ may have a regulatory function. PiT1 is
the only SLC20 paralog that can substitute Mg2+, albeit only partially, in the absence of Ca2+.
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PiT1 and PiT2 transporters are highly related, but there are a few differences. A notable
functional difference is that PiT2 is the only isoform that can mediate Na+-independent Pi
transport by translocating H+ (3).
There are no known inhibitors of SLC20 family proteins. In contrast, NaPi-II proteins are
inhibited by PFA. Although there are reports that PFA inhibits PiT proteins, the PFA
concentration was high (>10 mM) and the membrane potential was not controlled, indicating that
the inhibition might be nonspecific. Although there are no inhibitors of PiT2, arsenate does
compete with Pi to reduce Pi transport in PiT proteins. These effects are similar in NaPi protein
isoforms (33).

SLC20 and SLC34 in a Physiological System
The unrelated SLC20 and SLC34 families are unique because of their specificity for one
of two phosphate species at physiological pH. Distinguishing characteristics of each family and
its paralogs are displayed in Table 1. It is unclear whether these functional differences have any
impact on the proteins’ physiological purposes. It should be noted that transporting either of the
phosphate species will change the pH due to the equilibrium shift. The two solute carrier families
differ in their optimum pH range but have an overlapping pH of 6.8. The PiT proteins have the
greatest transport rate in the acidic range whereas the NaPi proteins favor transport in the
alkaline range. Interestingly, the difference in substrate stoichiometry and preferred Pi species
creates a 100-fold difference in Pi concentrative capacity. The difference in substrate
stoichiometry may have physiological implications. NaPi-IIc transports one less Na+ ion and is
electroneutral. Thus, NaPi-IIc-mediated transport has a smaller energetic cost because less Na+ is
loaded into the cell and less energy is needed to keep the cell at a negative membrane potential
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(33). PiT-type transporters could be favorable in the CNS because both PiT proteins respond to
variations in extracellular Pi concentrations and a persistent deficiency will increase PiT1 and
PiT2 mRNA. On the other hand, NaPi-II-type transporters are more sensitive to dietary Pi intake
and hormonal factors.

1.4 Phosphate Transport in Other Tissues
To better understand phosphate transport in the CP, it is useful to first consider phosphate
transport in other tissues. The kidneys and the small intestines are two sites that are important in
the maintenance of systemic Pi homeostasis and a brief review of phosphate balance in each
organ is given below.

Renal Phosphate Transport
The major site of Pi maintenance resides in the kidneys, primarily in the proximal
tubules. The human kidneys are responsible for the reabsorption of 80% of the free phosphate
ions that are filtered by the glomeruli with approximately 60% to 70% reabsorbed in the
proximal tubules and 10 to 20% in the distal sites (17). The principle and rate-limiting step in Pi
reabsorption is mediated by sodium-dependent Pi transporters that are in the brush border
membrane. NaPi-II-type and PiT-type transporters are both present in the kidney, with the
former as the central transporter (17, 18, 27) (Figure 5). The brush border membrane has both
NaPi-IIa and NaPi-IIc isoform, and NaPi-IIa knockout mice have designated this isoform as the
major player in systemic Pi homeostasis. This was supported by the 70% reduction in sodiumdependent Pi cotransport in the apical membrane in NaPi-IIa knockout mice. The NaPi-IIc type
KO mice model demonstrated that the type IIc transporter accounts for 30% of renal Na/Pi
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mediated transport in the brush border membrane. PiT1 and PiT2 mRNA have been detected in
proximal tubular cells but their protein localization has yet to be determined (17). Figure 5 is a
schematic of the Pi transport in renal cells.

Intestinal Phosphate Transport
The U.S Department of Agriculture’s Continuing Survey of Food Intakes by Individuals
suggests a daily phosphorus intake in the range of 1,600 to 2,400 milligrams for males and 1,200
to 1,600 milligrams for females. Fortunately, phosphorus is abundant in almost all food types
and is ingested as Pi. Phosphates in the diet exist first as organic molecules that must be broken
down by digestive enzymes to release Pi into intestinal fluids. The freed Pi is then ready for
absorption by the intestine (9).
The primary site of Pi absorption is along the entire length of the small intestine, with
some absorption at the colon when intestinal luminal Pi concentrations are extremely high. In
vitro studies involving voltage clamp analysis or radiolabeled uptake have proven the existence
of an active sodium-dependent Pi transport pathway in intestinal cells..
The active transport of Pi is mediated by NaPi-II-type transporters and PiT-type
transporters. Unlike the kidney, the small intestines employ the NaPi-IIb isoform for sodiumdependent, inward transport of extracellular Pi. NaPi-IIb-type transporters have a relative high
affinity for Pi (Km 10 µM), which suggests that NaPi-IIb can be saturated under most dietary
conditions and is effective at transporting Pi even under conditions of dietary phosphate
depletion. NaPi-IIb knockout studies have been performed in mice, and although decreased
intestine phosphorus absorption has been reported in the KO mice, serum phosphorus and
calcium concentrations were kept constant (25). This phenomenon may be explained by
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compensatory mechanisms by the renal NaPi-IIa-type transporter and suggests that NaPi-IIb may
be involved in the regulation of systemic Pi levels.
Approximately 10% of the sodium-dependent Pi transport is not attributable to NaPi-IIbtype transporters, resulting in the search for other Pi transporters in the small intestine. Although
PiT proteins have been found in the basolateral membrane in a variety of tissues, evidence has
demonstrated that PiT1 protein and PiT2 protein are actually expressed on the apical side of
enterocyte epithelium. Literature has shown that NaPi-IIb-type and PiT-1-type transporters are
primarily expressed in the duodenum and jejunum of rat small intestine (25). The role of PiT
transporters in the small intestines has yet to be determined.

1.5 Radiolabeled Phosphate Uptake Studies in Rat Z310 Choroid Plexus Epithelial Line
The present study is based on the observations of radiolabeled phosphate uptake by rat
Z310 choroid plexus epithelial cells (Bataille et. al. (Unpublished)). The study showed that
radiolabeled Pi uptake by Z310 cells increased as a function of time (Figure 6) and was not
saturated at normal CSF Pi concentrations (0.9 mM) (Figure 7A). The Eadie-Hofstee plot (Figure
7B) was generated by studying the transport of Pi by the Z310 cells at increasing external Pi
concentration and indicated a Km=0.56 mM and Vmax= 7.68 nmoles/mg protein/5 minutes.
Furthermore, Bataille et al. (unpublished) conducted studies which suggested that the primary Pi
transporter is electrogenic and Na+ dependent, but can substitute Na+ with Li+ (Figure 8). This
was evident by the inhibition of Pi uptake in the absence of sodium and by plasma membrane
depolarization induced by high potassium Ringer and a diminished sodium gradient created by
inhibiting Na+/K+/ATPase by 1 mM ouabain. Additionally, transporter inhibition studies were
performed, and reduced Pi transport was observed in the presence of arsenate and antimycin A
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when compared to the control. There was no change in transport when the Z310 cells were
incubated with phosphonoformic acid (PFA) or methazolamide. (Figure 9).
The uptake studies conducted by Bataille et al. (unpublished) described Pi uptake in Z310
choroid plexus cells as sodium-dependent, able to partially substitute Na+ with Li+, electrogenic,
and inhibited by arsenate but not PFA. Based on Table 1(33), the Pi uptake properties are
consistent with those of PiT-like transporters. In addition, Bataille et. al. performed PiT2
localization studies in Z310 CP cells (Figure 10) that show that PiT2 protein is present and
appears to be localized to the plasma membrane.

1.6 The Present Study
The cerebrospinal fluid provides the optimal environment for neurons to properly
function. Interestingly, CSF Pi concentrations are one-half that of blood plasma. Thus, we
questioned why the brain parenchyma prefers a lower Pi concentration than its plasma
counterpart. We sought to determine the primary mechanism of Pi transport from the
cerebrospinal fluid to plasma. Bataille, et al. (unpublished) conducted extensive radiolabeled
uptake Pi in Z310 CP epithelial cells that suggest that the PiT family is the principle pathway for
Pi to exit the CSF. This was based on electrogenic and sodium-dependent Pi transport along with
partial transport when Na+ was substituted with Li+ and inhibition by arsenate but not PFA.
However, it remained to be determined whether NaPi-II-type transporters are present or absent in
the CP. Therefore, the present study examined the presence of NaPi-II type family in CP
secondary-active Pi transport in rat choroid plexus epithelial cells. To do this, semi-quantitative
RT-PCR and western blotting studies were performed to determine if NaPi-II mRNA and protein
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are expressed. Our results indicate that NaPi-IIb-type transporters may be in the rat choroid
plexus, along with PiT1 and PiT2 transporters.

2. MATERIALS AND METHODS
2.1 Animal and Tissue Preparation
Intact rat choroid plexus, renal proximal tubule, gut, and lung tissues were from Sprague
Dawley rats of mixed gender and varying ages and weight. Tissues were stored in RNAlater
RNA stabilization reagent (Qiagen). The adult rat choroid plexus epithelium tissues in primary
culture were from the lateral ventricle and were provided by Dr. Alice Villalobos. All tissues
were stored at -20°C and thawed on ice prior to use.

2.2 Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) and PCR Product
Visualization
RT-PCR analysis was conducted on adult and neonate rats for semi-quantitative mRNA
analysis of NaPi-II-type and PiT-type transporters. Total RNA was extracted from adult and
neonate rat choroid plexus cells, rat renal proximal tubule cells, rat gut cells, and rat lung cells
using a Qiagen RNeasy mini kit. A Thermo Scientific Nanodrop was used to measure RNA
concentrations. Twenty-five microliter RT-PCR master mixes were prepared using a Qiagen
OneStep RT-PCR kit. 1 µg of total RNA of each sample was added to each master mix, which
had a final reverse and forward primer concentration of 0.6 µM. The primers were designed
against rat NaPi-IIa (SLC34A1, Accession # NM_013030.1, 630 BP), rat NaPi-IIb (SLC34A2,
Accession #NM_053380.2, 856 BP), rat NaPi-IIc (SLC34A3, NM_139338.1, Set 1 513 BP, Set
4 786), rat PiT1 (SLC20A1, Accession # NM_031148.1, 758 BP) and rat PiT2 (SLC20A2,
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Accession # NM_017223.2, 337 BP). Table 2 shows the nucleotide sequence, the nucleotide
correspondence, and the amplified fragment size of each primer.
RT-PCR was conducted in a PCR Sprint thermocycler (Thermo Electron Corporation).
PCR amplification begins with an initial heating step at 50°C for thirty minutes and then 95°C
for fifteen minutes to activate the HotStarTaq DNA polymerase. The cycle parameters are as
follows: 94°C denaturing for 1 minute, 56°C annealing for 1 minute, and 72° extension for 1
minute. The thermocycler was programmed for 32 cycles. Final extension was at 72°C for ten
minutes and then held at 4°C until products were removed from the thermocycler.
PCR products were visualized on a 1% agrose gel with 0.1% of GelStar (nucleic acid
stain). Fifteen microliters of the samples were loaded with 3 µL of 6X loading buffer (glycerol,
0.5 M EDTA pH 8.0, 1% bromophenol blue). The gel was run at 70 V for approximately 3
hours. A 1 KB plus DNA ladder (Invitrogen) was loaded and a UV detector was used to visualize
the bands.

2.3 Western Blotting
PiT1, PiT2, and NaPi-IIb protein expression was analyzed by western blotting. Intact rat
choroid plexus cells were vigorously vortexed with 250 µL distilled H2O, 2.5 µL 1M KOH, and
5 µL 2% protease inhibitor cocktail and then centrifuged at maximum speed for 1 minute. The
supernatant was measured for protein concentration by Bio-Rad protein assay and then diluted
2X with Kaman buffer. The samples were not boiled prior to electrophoresis. Proteins were
separated by SDS-polyacrylamide gel electrophoresis at 120 V for 3 hours. The resolving and
stacking gel was 10-12% and 4% acrylamide, respectively. Approximately 40 µg of each sample
was loaded into each lane. A 5 µL full range rainbow MW marker (GE Healthcare) was also
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loaded to measure protein size. Proteins were transferred to a polyvinylidene difluoride
membrane using a transfer buffer (25 mM tris base, 192 mM glycine, 10% MeOH, 0.01% SDS,
pH 8.3) and blocked with 3% PBS/tween/milk. The blot was probed with primary antibody in
3% PBS/tween/milk (PiT1, PiT2, NaPi-IIb 1:500 dilution; β-actin 1:500 dilution). The
membrane was incubated with PiT2, PiT1, and NaPi-IIb primary antibody overnight whereas βactin antibody was incubated with the membrane for 2 hours. Secondary antibody conjugated to
horseradish peroxidase (HRP) was then added for approximately 1 hour. ECL western blotting
reagent (Pierce) was used for band detection and exposed on ECL hyperfilm.
Rabbit NaPi-IIb antibody (Accession # Q9DBP0) was from Abbiotec Company, San
Diego, CA, rabbit anti-PiT1 (74 kDa) was obtained from Santa Cruz Biotechnology, Inc., and
Dr. Victor Sorribas of the Universidad de Zaragoza provided us with the rabbit anti-PiT2. The
secondary antibody was a goat anti-rabbit conjugated to horseradish peroxidase (Sigma Aldrich).
The anti-β-actin was from Sigma-Aldrich.

3. RESULTS
3.1 Results of RT-PCR of Adult and Neonate Rat Choroid Plexus
RT-PCR was performed to determine the presence or absence of SLC34 and SLC20
mRNA in adult and neonate rat choroid plexus cells. To ensure that the SLC34 and SLC20
primers were properly functioning, negative and positive control RT-PCR analyses were
conducted. Several sources have confirmed the presence of NaPi-IIa and NaPi-IIc but not NaPiIIb in the kidney (17, 18, 33). In contrast, the intact rat gut tissue has been reported to exclusively
express the NaPi-IIb isoform (18, 25, 33). Figure 11A and 11B show the results of the RT-PCR
of intact rat renal proximal tubule tissue and intact rat gut tissue. The RT-PCR confirmed the
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presence of NaPi-IIa (~630 bp) and NaPi-IIc ((1) ~513 bp, (2) ~786 bp) in the rat renal proximal
tubule; however, there was also a signal for NaPi-IIb (~856 bp). Since the proximal tubule tissue
used in this analysis was intact, there was more than just nephron tissue in each sample. The
extraneous tissue could be blood cells, endothelial cells or smooth muscle tissue that could
account for the NaPi-IIb mRNA signal. The RT-PCR of the rat gut cells showed a signal for the
NaPi-IIb isoform but not for NaPi-IIa and NaPi-IIc mRNA. This is consistent with the literature
and further confirms the functionality of the primers.
After testing the integrity of the primers, RT-PCR analysis was conducted on intact rat
choroid plexus tissues to determine the presence of any NaPi-II isoform. The results are
displayed in Figure 13 with rat kidney used as the control. There were no bands detected for any
of the NaPi-II isoforms in rat CP but strong signals for NaPi-IIa (~630 bp) and NaPi-IIc (~786)
and a weak signal for NaPi-IIb in the kidney tissue (~856 bp).
Additionally, a RT-PCR was performed on intact adult rat CP using PiT1 (~758 bp), PiT2
(~337 bp), and NaPi-IIb (~856 bp) primers. The results are shown in Figure 12A. There was no
PiT1 mRNA detection but there was a strong signal for PiT2 and a weaker signal for NaPi-IIb. A
repeat of the preceding analysis was performed, but we used isolated choroid plexus epithelium
in primary culture of adult and neonate rats as our samples. Figure 12B shows the results of the
RT-PCR, which show a signal for both PiT1 and PiT2, albeit PiT2 had a stronger signal. No
NaPi-IIb mRNA was detected in adult and neonate rat samples. Thus, it is not definitive whether
NaPi-IIb mRNA is present in rat choroid plexus epithelium.
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3.2 Results of Primary Rat Choroid Plexus Western Blot
The results from the RT-PCR have excluded the presence of NaPi-IIa and NaPi-IIc
mRNA in the rat CP but confirmed the presence of PiT2 mRNA in the CP. The RT-PCR data on
PiT1 and NaPi-IIb mRNA was inconclusive and a western blot was performed to determine
protein expression. A western blot was also done to confirm PiT2 protein expression. Intact
human choroid plexus tissues were analyzed alongside intact rat CP. The results are revealed in
Figures 14 (PiT1 Expression), Figure 15 (PiT2 Expression), and Figure 16 (NaPi-IIb
Expression). PiT1 expression was established in the rat and human CP by the presence of a band
at ~74 kDa. Additionally, the immunoblot revealed the presence of PiT2 protein in rat and
human CP by a band at ~72 kDa. The PiT2 western blot also showed bands present at ~76 kDa,
and ~140 kDa that can be explained by glycosylation and dimerization, respectively (26, 33).
The NaPi-IIb immunoblot indicated that NaPi-IIb proteins are expressed in the human and rat CP
by the presence of a ~108 kDa band. Rat lung, which has been confirmed to only have NaPi-IIbtype transporters, was used as a positive control (8). Each immunoblot also included assay of βactin (~42 kDa) to ensure equal protein loading between each sample. In the rat lung sample, the
β-actin sample showed three bands. This is because of cell apoptosis which results in cleavage
products. The initial cleavage results in a band at 41 kDa that appears as a doublet and further
cleavage gives a major band at 30 kDa. The cleavage products could be a result of the actions of
interleukin 1β-converting enzyme (1, 11).
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4. DISCUSSION
This study attempted to address how Pi is actively transported out of the CSF. The
Bataille et al. radiolabeled Pi uptake studies suggested that Pi transport has PiT-like
characteristics. However, it has not been determined whether NaPi-II-type transporters play a
role in mediating Pi transport. Figure 12A and Figure 12B display the results of an RT-PCR of rat
CP and suggest the presence of PiT1, PiT2, and NaPi-IIb mRNA in the CP. The RT-PCR in
Figure 12A showed that neonate and adult rat CP have PiT1 and PiT2 mRNA, with a stronger
signal for PiT2 mRNA. Another sample of adult rat CP was also analyzed by RT-PCR with the
same three primers and was revealed to have NaPi-IIb mRNA and PiT2 mRNA expression.
Although PiT2 was found in all three samples, PiT1 and NaPi-IIb mRNA expression in the rat
CP samples were inconsistent. This may be explained by the difference in sample preparation in
Figure 12A and Figure 12B. In Figure 12A, the rat CP samples were isolated rat choroid plexus
epithelium in primary culture whereas the samples in Figure 12B were intact rat choroid plexus
tissue. The intact rat choroid plexus tissue has more than just CP epithelium. The choroid
plexuses are leaf-like structures with rich capillary beds that are attached to the ependyma by a
thin stalk. Additionally, the CP is lined with the ependyma to form its outer covering (23).
Therefore, intact rat CP could include endothelial cells, smooth muscle, blood cells, and
ependymal tissue that may have NaPi-IIb-type transporters.
In addition, Lau et al. reported PiT1- and PiT2-type transporters expression in rat
vascular smooth muscle cells, with PiT1-type transporters more abundant than PiT2-type
transporters. No NaPi-II isoform expression was seen (12, 30). Moreover, Di Marco et al. studied
hyperphosphatemia, phosphate transport, and endothelial cell apoptosis. The investigators found
PiT1 mRNA in endothelial cells but have not ruled out the presence of other Pi transporters. The
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investigators also found that PFA prevented phosphate-induced apoptosis, suggesting that NaPiII transporters may be present in endothelial cells (14). Thus, tissue contamination could account
for the PiT1 and NaPi-IIb signal.
This type of contamination can be seen in our control samples. In Figures 11 and Figure
13, the rat kidney was used as a control to ensure the specificity of NaPi-II primers. According
to Murer, et al, renal proximal tubules only contain NaPi-IIa- and NaPi-IIc-type transporters,
which was confirmed in the RT-PCR; however, we detected a signal for NaPi-IIb, which has
been reported to be absent from the nephron (18). The intact rat kidney tissue included not just
proximal tubule but endothelial cells, blood cells, and smooth muscle cells. Thus, this may be an
example of contamination that could cause a false-positive for NaPi-IIb and explain the NaPi-IIb
signal in the rat CP samples.
In addition to RT-PCR analysis, western blot analysis of PiT1, PiT2, and NaPi-IIb was
performed to determine protein expression. The immunoblots indicated that intact rat CP have
PiT1, PiT2, and NaPi-IIb proteins. Moreover, intact human CP samples were analyzed for
protein expression and suggest the presence of PiT1, PiT2, and NaPi-IIb transporters. Because
intact CP tissues were used, samples contained other tissues besides CP epithelium tissues that
could account for the band in the immunoblot.
The contamination of CP with non-target tissues has been problematic in our study.
Although it is likely that PiT2-type transporters are the principle transporter in the CP, we cannot
rule out PiT1 and NaPi-IIb. Thus, we must do immunohistochemistry studies to determine the
localization of these transporters.
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Pi Cellular Homeostasis and CP Function
Although the results suggest that NaPi-IIb could possibly play a role in CP Pi transport,
PiT2-type transporters seem to have a definite role in Pi transport out of the CSF. This has been
suggested by the PiT-like Pi uptake, PiT2 mRNA and protein expression, and the apparent PiT2
localization in the plasma membrane of Z310 CP cells. These observations raise the question of
why choroid plexus cells have PiT-type transporters instead of NaPi-II-type transporters. NaPi-II
transporters are primarily expressed in the kidney and the gut, which reflects the SLC34 family’s
principle role as the regulator of systemic Pi homeostasis. In contrast, because PiT-like
transporters have wide tissue distribution, it has been suggested that they function as a regulator
of cellular Pi homeostasis. PiT-1-like and PiT-2-like transporters have been found in all
investigated human tissues, although at different levels. Moreover, PiT mRNA is regulated by
various factors that include epinephrine, platelet-derived growth factor (PDGF), insulin-like
growth factor (IGF-1), and most importantly, Pi concentrations (33). Reports have shown that
persistent Pi starvation increases PiT1 and PiT2 mRNA. Interestingly, the [Pi] regulation of PiT2 transporters results in the formation of PiT-2 dimers, suggesting that PiT2 proteins play a role
in phosphate sensing. Phosphate uptake is 4.5 and 2.5 times more efficient in phosphate deprived
conditions than at 10 mM. In addition, PiT2 activity changes within minutes of Pi concentration
variations. The adaption to Pi concentrations occurs without any significant modification to the
number of PiT2 proteins, but rather a change in PiT2 structure, as seen in Figure 17. Salaün et al.
reported that PiT2 assemblies, particularly those at the cell surface, may switch between two
conformations. The proportion of individual PiT2 molecules that can be cross-linked is high in
low extracellular Pi concentrations but is low in high extracellular Pi concentrations. Moreover,
human PiT2 has positive cooperativity characteristics that are reflected by the dimerization of
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human PiT2 in Pi starved environments (26). The ability of PiT-type transporters to finely sense
extracellular Pi concentrations and quickly adapt to extracellular Pi concentrations is favorable
for maintaining the CSF environment.
The Pi sensitivity of PiT-type transporters is essential if the primary function of the brain
choroid plexus is taken into account. The ability to mediate the transport of solutes and produce
cerebrospinal fluid is an energetically expensive process. Thus, the choroid plexus contains a
high volume of mitochondria to support CSF secretion and maintain ionic gradients. In fact,
Cornford, et al. reported a high mitochondrial volume (>13% of cytoplasmic volume) in
mammalian choroid plexus cells that exceeds any previously reported brain cell (5). Pi plays a
major role as a structural component of ATP and its uptake into the CP is essential for its
function. If PiT-transporters are responsible for cellular Pi homeostasis, then its sensitivity to Pi
is more optimal for providing enough ATP for CP function.

CSF pH and PiT-Type Transporters
One of the most interesting, unexplained phenomenons of the CNS is the ability of the
CSF to maintain a constant pH in the absence of protein. Because of the lack of protein, it seems
likely that the CSF contains a large buffer concentration, particularly Pi, a dominant
physiological buffer. However, CSF Pi concentrations are held between 0.5 and 1.0 mM, about
one-half the Pi concentration of the plasma (2). This low CSF Pi concentration is unexplained but
may still play a role in the maintenance of CSF pH. A major difference between the SLC20 and
SLC34 transporter gene families is their optimal pH range and preferred Pi substrate. The PiT
proteins favor transport in the acidic range, and because PiT-type transporters favor H2PO4-, PiTmediated Pi transport would alkalinize the CSF. However, the most notable characteristic of PiT2
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transporter is the ability to co-transport Pi with H+, unlike the NaPi-II-type transporters. Thus,
PiT-mediated transport may be optimal because it can operate at low pH and at the same time
alkalize the CSF. In fact, PiT2 is the only sodium-dependent Pi transporter that can undergo Na+independent-Pi transport by translocating H+.

Central Control of Phosphate Appetite in Rats and Role of PiT-Type Transporters
The lack of any essential nutrient in the diet has physiological implications. For example,
zinc, magnesium, and potassium deficiency disrupt body growth and affect food intake variation.
A disturbance in Pi homeostasis has serious repercussions, including bone abnormalities, stunted
growth, and metabolic disorders. Typically, mineral deficiencies cause an increase in Na+
ingestion; however, this is not the case with Pi, suggesting that Pi appetite is specific to Pi
concentrations. Several groups have reported that dietary Pi has a direct effect on Pi craving. In
2007, Ohnishi et al. performed a study that investigated whether a lowered Pi concentration in
plasma and CSF will induce a Pi appetite in rats. The results showed that rats that were under a
low Pi diet consumed 70%-100% more Pi than normal Pi diet rats. Moreover, low Pi diet rats had
a significant reduction in Pi concentrations in the CSF and plasma (20). These results
demonstrate that Pi appetite can be induced in rats and suggest that its action is through lowered
plasma and CSF Pi concentrations.
The Ohnishi et al. study indicates that there is some central control that regulates Pi
concentrations. However, it is unknown how the body manages to sense low Pi concentrations.
The PiT-type family could potentially explain this phenomenon if it is present in the apical
membrane of choroid plexus cells. As seen in Figure 17, PiT-type transporters adapt a
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conformation that reflects the presence of a low or high Pi concentration and could potentially act
as the Pi sensor in CSF (26).

PiT2-Type Transporters, Calcium, and Inhibitors
The SLC20 family of transporters is also distinguished by the modulatory effects of
divalent ions. PiT1- and PiT2-type transporters exhibited impaired, albeit sufficient, Pi transport
in the absence of Ca2+ and Mg2+. Of the two divalent ions, Ca2+ increased Pi transport more
significantly, suggesting that Ca2+ may regulate PiT function (3). The role of Ca2+ in CP Pi
transport is noteworthy because of the concerted homeostasis of calcium and phosphate. As
previously discussed, hypocalcemia increases neuronal permeability to Na+ which can result in
CNS hyperexcitability whereas hypercalcemia can cause CNS depression. Thus, the unique
ability of PiT-type transporters to be modulated by Ca2+ could be beneficial to maintaining an
optimal milieu for the CNS.
The last major advantage of the PiT family is its lack of reported inhibitors, unlike the
NaPi-II family, which is reported to be inhibited by PFA (33). This is a major benefit that
ensures that the CP and CSF obtain sufficient amounts of Pi.
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5. CONCLUSIONS
The present study focused on Pi transport out of the CSF and into CP cells. Although
more studies need to be performed to determine the mechanism of CP Pi transport, it is likely
that PiT2-type transporters play the largest role in mediating Pi out of the CSF, with a smaller
contribution from PiT1-type transporters. Although Bataille et al. reported PiT-like Pi uptake,
NaPi-IIb-type transporters may contribute to CP Pi transport. Figure 18 is a proposed model for
CP Pi transport. The apical membrane may have PiT1, PiT2, and/or NaPi-IIb but all transport is
electrogenic, bringing in a net positive charge. PiT-mediated transport introduces a positive
charge, along with a build-up of H2PO4- and Na+. To prevent the accumulation of H2PO4- and a
positive potential, there must be a transporter at the basolateral membrane that pushes H2PO4- out
of the CP cell. The removal of H2PO4- alkalizes the cell while also removing a net negative
charge. A potential basolateral transporter that is capable of balancing the removal of H2PO4 is
the Cl-/HCO3- exchanger, AE2. This transporter has been reported to be localized exclusively to
the basolateral membrane of the mammalian CP and is known as a Cl- loader and base extruder
(7). Thus, the acidic H2PO4 is pushed out of the CP with the basic HCO3-. Moreover, a sodium
gradient must be sustained to continue to the uptake of Pi.
More work needs to be performed to perfect the CP Pi transport model. However, the
significance of this study is that we now know that NaPi-IIa and NaPi-IIc transporters are not
present in the choroid plexus. Determining the mode of CP Pi transport is important because
physiological impact of Pi. Future work in CP Pi may help us clinically by explaining such
phenomena as CSF formation or acid-base balance that when deregulated cause such pathologies
as congenital hydrocephalus or CNS acidosis.
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FIGURE 1. Cartoon Representation of Adult Human Brain Ventricles by Lowry et. al.
Blue is brain tissue, yellow is the brain ventricles, and red is the choroid plexuses. The blue
arrows show the direction of CSF flow. LV= Lateral Ventricle, 3V= Third Ventricle, 4V=Fourth
Ventricle
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FIGURE 2.Schematic Representation and Differential Interference Contrast Micrograms
of Mouse Choroid Plexus by Damkier et. al. (A) Schematic representation of the brain and its
ventricular system. Choroid Plexus is in orange, cerebrospinal fluid is in light blue, brain
parenchyma is in gray, meninges in dark blue, and skull in green. III V. is the third ventricle and
IV V is the fourth ventricle. (B) Differential interference contrast micrograph of the mouse
fourth ventricle and choroid plexus at low magnification. (C) Higher magnification of a single
villus of the same choroid plexus.
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Choroid Plexus Epithelium

FIGURE 3. Morphology of Blood-CSF Interface by Johanson et. al. The choroid plexus is a
monolayer of cicumferentially arranged epithelial cells with a fenestrated capillar at its center
and contains numberous mitochondria. The CP capillaries, unlike other brain caplicaries, are
permeable to macromolecules.
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FIGURE 4. A Schematic Section through the Brain and Spinal Cord Showing the Drainage
Pathways for CSF. CSF is formed by the choroid plexuses of the lateral ventricle (CPLV) and
passes by the two foramina of Munro (FM) into the third ventricle (CPV3), where more CSF is
produced by the CP. CSF then flows through the aqueduct of Sylvius (AS) and into the fourth
ventricle. The CSF exits into the various basal cisterns (CI, CS) and then into the subarachnoid
space (SAS) through the paired foramina of Luschka (FL) and single foramen of Magendie
(FM). CSF flows through the subarachnoid space over the surface of the cortex. Some fluid
drains into the blood via the arachnoid granulation (AG) into the superior sagittal sinus (SSS).
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FIGURE 5. Localizations and Substrates of Sodium-Dependent Pi-Type Transporters in
the Kidney. The brush border membrane has NaPi-IIa (Red), NaPi-IIc (Green), and PiT2 (Blue)
transporters, whereas the basolateral membrane has Na+-K+-ATPase (Purple) and an unknown
transporter (Orange) that mediates the movement of Pi back into the blood plasma.
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FIGURE 6. Summary Data-Pi Uptake in Z310 Rat CP Epithelial Cell Line as a Function of
Time. Pi uptake was determined by the amount of radiolabeled Pi inside the cells at different
time intervals. The amount of Pi inside the cell was normalized by the protein concentration of
each sample. The figure demonstrates that uptake is linear at t= 5 minutes and is used as time
frame for the other uptake experiments.
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FIGURE 7. (A) Summary data of the Pi uptake in Z310 rat CP epithelial cell line at different
external Pi concentrations. Uptake was determined by the amount of radiolabeled Pi inside the
cells at t= 5 minutes and was normalized by the protein concentration of each sample. The results
show that Pi uptake is not saturated at physiological Pi concentration (0.9 mM). (B) A EadieHostee plot was created from the summary data and revealed that Pi uptake has a Km of 0.56 mM
and Vmax of 7.68 nmoles/mg protein/5 minutes.
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FIGURE 8. Summary Data of Pi Uptake in Z310 Rat CP Epithelial Cell Line in the
Presence and Absence of Several Ions and Gradients. CP cells were pre-incubated in their
respective treatments for 30 minutes before radiolabeled Pi was added at t=0 minutes. Uptake
was then determined by measuring the amount of radiolabeled Pi inside the cells at t=5 minutes
and normalizing the amount by the protein concentration of each sample. (A) Pi uptake is
inhibited when NaCl is removed from the medium (sodium-free ringers). However, uptake was
partially restored when 120 mM LiCl (lithium ringers) was added. (B) Pi uptake is inhibited by
plasma membrane depolarization that was induced by high potassium Ringer (100 mM KCl) and
by a diminished sodium gradient. The diminished sodium gradient was created by inhibiting the
Na+/K+/ATPase by 1 mM ouabain.
*Significantly different from the control or sodium ringers
** Significantly different from sodium-free ringers
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FIGURE 9. Summary Data of Pi Uptake in Z310 Rat CP Cell Line in the Presence of
Various Known Phosphate Transporter Inhibitors Cells were pre-incubated in their
respective inhibitor treatments for 30 minutes before radiolabeled Pi was added at t=0 minutes. Pi
uptake was determined by the amount of radiolabeled Pi inside the cells at t= 5 minutes and was
normalized by the protein concentration of each sample. Arsenate (10 mM) and antimycin A (0.1
mM) inhibited Pi uptake when compared to controls. There was no change in Pi uptake when the
cells were incubated with 1 mM PFA or 0.1 mM methazolamide.
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FIGURE 10. Fluorescence Immunohistochemistry Analysis of PiT2 Protein Expression in
the Z310 Choroid Plexus Epithelial Cell Line. PiT2 staining was done with a commercially
available anti-PiT2 (Sigma Aldrich) and a fluorescently tagged secondary antibody (green).
Controls were labeled with secondary antibody only. The nuclei were visualized with Hoesct
stain (blue).
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FIGURE 11. Semi-Quantitative RT-PCR Products of mRNA Extracted from Rat Kidney
and Rat Gut. Primers were designed against the rat mRNA sequences for NaPi-IIa (SLC34A1,
accession # NM_013030.1, 630 bp), NaPi-IIb (SLC34A2, accession #NM_053380.2, 856 bp),
and NaPi-IIc (SLC34A3, accession # NM_139338.1 , (1) 513 bp, (2) 786 bp). (A) RT-PCR was
conducted in the kidney where NaPi-IIa and NaPi-IIc are known to occur. (B) The gut has been
reported to have NaPi-IIb-type transporters. Thus, RT-PCR analysis was performed in the rat gut
as positive and negative controls for the NaPi-II isoforms.
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FIGURE 12. Semi-Quantitative RT-PCR Products of mRNA Extracted from Rat CP.
(A) Total mRNA was extracted from adult and neonate rat choroid plexus epithelium in primary
cultures, compliments of Dr. Alice Villalobos. The adult rat choroid plexus was from the IV
ventricle. NaPi-IIb (SLC34A2, accession #NM_053380.2, 856 bp), PiT1 (SLC20A1, accession #
NM_031148.1, 758 bp), and PiT2 (SLC20A2, accession # NM_017223.2, 337 bp) mRNA
primers were used. (B) Primers were designed against NaPi-IIb, PiT1, and PiT2 mRNA and used
in RT-PCR analysis in adult rat choroid plexus.
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FIGURE 13. Semi-Quantitative RT-PCR Products of mRNA Extracted from Rat Choroid
Plexus and Rat Kidney. All three NaPi-II isoform primers were used in RT-PCR analysis of rat
kidney and rat CP. Rat kidney was used as a positive control for NaPi-IIa and NaPi-IIc but acted
as a negative control for NaPi-IIb. (NaPi-IIa: 630 bp, NaPi-IIb: 856 bp, NaPi-IIc: 786 bp)
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FIGURE 14. Western Blot Analysis of PiT1 Transporter Expression in Intact Rat and
Human CP tissue. Rat and human choroid plexus cell proteins were separated by SDS-PAGE
electrophoresis and transferred to a PVDF membrane. The membranes were probed with primary
rabbit anti-PiT1 (Santa Cruz Biotechnology) and rabbit anti-β and stained with the secondary
antibody, goat anti-rabbit HRP-conjugated IgG. Bands were visualized by ECL luminescence.
PiT1 (74 kDa), β-Actin (~42 kDa)
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FIGURE 15.
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FIGURE 15. Western Blot Analysis of PiT2 Expression in Rat and Human Choroid Plexus
Cells. 40 µg samples of rat and human choroid plexus cells were loaded and separated by 12%
SDS-PAGE gel electrophoresis. Immunoblots were stained with either PiT2 (From Sorribas, et.
al., ~72 kDa) or β-actin primary antibody (~42 kDa) and then secondary antibody (goat antirabbit Hrp-conjugated IgG). Bands were detected by ECL luminescence.
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FIGURE 16. Western Blot Analysis of NaPi-IIb Expression in Rat and Human Choroid
Plexus Cells. Approximately 40 µg of intact rat and human choroid plexus cells were separated
by electrophoresis on a 10% SDS-polyacrylamide gel and then transferred to a PVDF membrane.
The top gel was incubated overnight with primary rat anti-NaPi-IIb (Abbiotec Biotechnology,
~108 kDa), whereas the bottom gel was incubated with rabbit anti-β-actin (~42 kDa) for two
hours. ECL luminescence was used to visualize bands. Rat lung tissue was used as a positive
control.
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FIGURE 17. Schematic Representation of the Configuration of Cell Surface PiT2
Assemblies at Various [Pi] by Salaün et al. At low [Pi], PiT2 assemblies are in a “compact”
configuration, which allows cross-linking of monomers. This configuration mediates active Pi
uptake. (2, 3) At higher [Pi], PiT2 assemblies are in a relaxed configuration. The distance
between the monomers allows efficient cross-linking and is associated with inactive Pi uptake.

Le 49
FIGURE 18. Proposed Model of Pi Transport in Choroid Plexus Cells. Green= PiT2, Red=
Na+-K+-ATPase, Purple= Unknown Basolateral Pi Transporter, Blue= AE2
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Table 1. Properties of Sodium-Dependent Phosphate Transporters by Virkki et. al.
(2007)(Virkki et al., 2007)
Na+/Pi Cotransporters
NaPi-IIa
NaPi-IIb
NaPi-IIc
PiT-1
PiT-2

Substrates
Na+, HPO42-, Arsenate
Na+, HPO42-, Arsenate
Na+, HPO42-, Arsenate
Na+, H2PO4-, Li+, Arsenate
Na+, H2PO4-, Li+, Arsenate

Stoichiometry Na+/Pi
3:1
3:1
2:1
2:1
2:1

Electrogenic
Yes
Yes
No
Yes
Yes

PFA Block
Yes
Yes
Yes
No
No
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TABLE 2. Nucleotide Sequence, Nucleotide Correspondence and Fragment Size of Primers
used in RT-PCR Amplification.
Primer Name

Nucleotide Sequence

SLC34A1_For
SLC34A1_Rev
SLC34A2_For
SLC34A2_Rev
SLC34A3_For (1)
SLC34A3_Rev (1)
SLC34A3_For (2)
SLC34A3_Rev (2)
SLC20A1_For
SLC20A1_Rev
SLC20A2_For
SLC20A2_Rev

5’-TCC AGC ACC TCG ACA TCC ATC ATT-3’
5’-TGA GCA CAG CGT ATG ACT ATG GCA-3’
5’-TGA GCA CAG CGT ATG ACT ATG GCA-3’
5’-TGA GCA CAG CGT ATG ACT ATG GCA-3’
5’-TGA GAA ATG CAG GGA CCT CTG GTT-3’
5- AAG GCC CTC TGA AAT TCA TCC CGA-3’
5’-AAG GCA CTG ACT CGA CCT TTC ACA-3’
5’-AGA CAA TGG CTA CCC AGC GGT ATT-3’
5’- CAA ACA TTG GCC TTC CCA TCA GCA-3’
5’- TGC CAA AGA TTC TCG GCC CTC TAA-3’
5’-TGC AGT GGA TGG AAC TCG TCA AGA-3’
5’-TCT TCA TCC ACG GAC ACA CGA ACA-3’

Nucleotide
Correspondence
540
1146
2202
3035
162
651
803
1565
1898
2633
818
1132

Amplified
Fragment Size
630
630
856
856
513
513
786
786
758
758
337
337
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